Sunshine Guojian Pharmaceutical(Shanghai) Co.,Ltd. Posted 154.9 Million Yuan Net Profit in First Three Quarters of 2023

Sunshine Guojian Pharmaceutical(Shanghai) Co.,Ltd. (三生国健药业(上海)股份有限公司) (688336.SH) reported a net profit of 154.9 million yuan in the first three quarters of 2023, reversing a net loss of 6 million yuan for the same period in the previous year.

Meanwhile, the company posted 730.6 million yuan in revenue, up 38.5% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 367.9 million yuan in total liabilities, with a liability-to-asset ratio of 7.2%.